Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v1-EN
Language French English
Date Updated 2021-03-02 2021-01-12
Drug Identification Number 02431815 02431815
Brand name SANDOZ TOPIRAMATE TABLETS SANDOZ TOPIRAMATE TABLETS
Common or Proper name SANDOZ TOPIRAMATE TABLETS SANDOZ TOPIRAMATE TABLETS
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients TOPIRAMATE TOPIRAMATE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100FCT BO V1 CA 100FCT BO V1 CA
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-01-08 2021-01-08
Estimated end date 2021-02-26 2021-02-05
Actual end date 2021-02-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments